title: Relationships between changes in leptin and insulin resistance levels in obese individuals following weight loss.
abstract: Obesity can augment insulin resistance (IR), leading to increased risk of diabetes and heart disease. Leptin, ghrelin, and various fatty acids present in the cell membrane may modulate IR. In this study, we aimed to investigate the impact of weight loss on IR, serum leptin/ghrelin levels, and erythrocyte fatty acids, and studied the associations between changes in these variables. A total of 35 obese (body mass index ≥ 27) adults participated in a weight loss program for 3 months. IR was assessed using homeostasis model assessment for insulin resistance (HOMA-IR). The obese participants had a mean weight loss of 5.6 ± 3.8 kg followed by a 16.7% and 23.3% reduction in HOMA-IR and leptin (p < 0.001) levels, and an 11.3% increase in ghrelin levels (p = 0.005). The level of erythrocyte saturates decreased by 2.8%, while the level of n-3 polyunsaturates increased by 16.8% (all p < 0.05). The changes in leptin levels (-5.63 vs. -1.57 ng/mL) were significantly different (p = 0.004) in those with improved IR (changes in HOMA-IR < 0) than those without improvement (changes in HOMA-IR ≥ 0), though there were no differences in the changes of ghrelin (p = 0.120) and erythrocyte fatty acids (all p > 0.05) levels. After adjusting for age, gender, changes in ghrelin, and body fat, we found a significant correlation between decreases in leptin and less risk of no improvement in HOMA-IR levels [odds ratio (OR) = 0.69, p = 0.039]. In conclusion, a moderate weight reduction in obese participants over a short period significantly improved IR. This weight reduction concomitantly decreased serum leptin, increased ghrelin, and elevated some erythrocyte unsaturates. Only leptin correlated independently with IR improvement upon multivariable logistic regression analysis, which indicates that leptin may play a role in the modulation of IR following weight loss.
authors.affiliation: Faculty of Public Health, Kaohsiung Medical University, Taiwan.
authors.forename: Tsu-Nai
authors.initials: TN
authors.lastname: Wang
authors.forename: Wen-Tsan
authors.initials: WT
authors.lastname: Chang
authors.forename: Yu-Wen
authors.initials: YW
authors.lastname: Chiu
authors.forename: Chun-Ying
authors.initials: CY
authors.lastname: Lee
authors.forename: Kun-Der
authors.initials: KD
authors.lastname: Lin
authors.forename: Yu Yao
authors.initials: YY
authors.lastname: Cheng
authors.forename: Yi-Ju
authors.initials: YJ
authors.lastname: Su
authors.forename: Hsin-Fang
authors.initials: HF
authors.lastname: Chung
authors.forename: Meng-Chuan
authors.initials: MC
authors.lastname: Huang
mesh_terms: D000293:Adolescent; D000328:Adult; D015992:Body Mass Index; D005260:Female; D054439:Ghrelin / Q000097:blood; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D020738:Leptin / Q000097:blood*; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009765:Obesity / Q000378:metabolism*; D015431:Weight Loss / Q000502:physiology*; D055815:Young Adult
chemical_list: D054439:Ghrelin; D020738:Leptin
keywords: Ghrelin; Insulin resistance; Leptin; Polyunsaturates; Weight control
references.citation: Clin Chem. 2004 Sep;50(9):1511-25
references.pmid: 15265818
references.citation: J Clin Endocrinol Metab. 1999 Aug;84(8):2751-4
references.pmid: 10443673
references.citation: Lancet Oncol. 2010 Aug;11(8):741-52
references.pmid: 20594911
references.citation: Lipids. 1997 Feb;32(2):179-84
references.pmid: 9075208
references.citation: Menopause. 2007 Jan-Feb;14(1):38-44
references.pmid: 17075432
references.citation: Obesity (Silver Spring). 2008 May;16(5):1033-8
references.pmid: 18356846
references.citation: Science. 1998 Sep 11;281(5383):1683-6
references.pmid: 9733517
references.citation: Nutr Rev. 2006 Oct;64(10 Pt 1):435-48
references.pmid: 17063925
references.citation: J Nutr. 2007 Sep;137(9):2049-55
references.pmid: 17709441
references.citation: Obesity (Silver Spring). 2006 Nov;14(11):1931-9
references.pmid: 17135608
references.citation: Am J Clin Nutr. 2001 Feb;73(2):240-5
references.pmid: 11157319
references.citation: Prostaglandins Leukot Essent Fatty Acids. 2003 Feb;68(2):151-62
references.pmid: 12538079
references.citation: Acta Diabetol. 2002 Sep;39(3):105-10
references.pmid: 12357293
references.citation: JAMA. 2002 Apr 3;287(13):1706-9
references.pmid: 11926895
references.citation: Can J Biochem Physiol. 1959 Aug;37(8):911-7
references.pmid: 13671378
references.citation: Biol Res. 2008;41(1):59-68
references.pmid: 18769764
references.citation: Maturitas. 2008 Jan 20;59(1):62-71
references.pmid: 18164562
references.citation: N Engl J Med. 1993 Jan 28;328(4):238-44
references.pmid: 8418404
references.citation: Clin Endocrinol (Oxf). 2006 Feb;64(2):169-78
references.pmid: 16430716
references.citation: Nat Med. 1996 May;2(5):589-93
references.pmid: 8616722
references.citation: JAMA. 2010 Feb 17;303(7):623-30
references.pmid: 20159870
references.citation: Diabetes. 2002 Apr;51(4):1005-15
references.pmid: 11916919
references.citation: Am J Clin Nutr. 2006 Nov;84(5):1193-9
references.pmid: 17093174
references.citation: Int J Obes (Lond). 2005 Oct;29(10):1175-83
references.pmid: 16030519
references.citation: Diabetes. 2002 Oct;51(10):2911-4
references.pmid: 12351426
references.citation: Int J Obes (Lond). 2009 Apr;33(4):490-6
references.pmid: 19223845
references.citation: JAMA. 2003 Apr 9;289(14):1799-804
references.pmid: 12684358
references.citation: J Clin Endocrinol Metab. 2008 Aug;93(8):3051-7
references.pmid: 18492759
references.citation: Fertil Steril. 2009 Aug;92(2):660-6
references.pmid: 18973889
references.citation: Diabetologia. 2008 Jul;51(7):1261-8
references.pmid: 18491071
references.citation: J Clin Endocrinol Metab. 2004 Apr;89(4):1630-5
references.pmid: 15070922
references.citation: Diabetologia. 1985 Jul;28(7):412-9
references.pmid: 3899825